Electrical Stimulation of the Optic Nerve for People With Glaucoma
Tests electrical stimulation of the optic nerve through the skin in adults with glaucoma.
Plain-language title generated from the registry record
Registry title: Electrical Stimulation of the Optic Nerve in Patients With Glaucoma.
Key facts
- Where
- San Francisco, United StatesSee the site
Where in United States
- Glaucoma Center of San FranciscoSan Francisco, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Glaucoma Center of San Francisco
- Trial code
- NCT06693882
- Record updated
- 20 November 2024
- Original description
The goal of this observational study is to evaluate electrical stimulation of the optic nerve with the Eyetronic Nextwave System device as a possible treatment for glaucoma.Read full original descriptionShow less
Electrical Stimulation of the Optic Nerve in Patients With Glaucoma : Prospective Analysis of Perimetric Data up to 12 Months After Neuromodulatory Treatment.
The goal of this observational study is to evaluate electrical stimulation of the optic nerve with the Eyetronic Nextwave System device as a possible treatment for glaucoma.
The main question it aims to answer is:
Could this therapy be an option to counteract the loss of visual field seen in glaucoma and thus delay the progression of the disease?
Participants will have approximately 14-18 study visits during 12 months including 10 visits for the electrical stimulation treatment. The treatment involves electrically stimulating the optic nerve by an external approach via the facial skin.
Inclusion: Subjects 18 years or older who have glaucoma; Humphrey visual field mean deviation (MD) values between - 6 dB and -20 dB.
Exclusion: IOP lowering medication started less than six months before enrollment; Any intraocular surgery less than 6 months before enrollment; Epilepsy; Arterial hypertension without appropriate treatment; Acute retinal hemorrhage; Age < 18 years; Implanted electronic devices; Metallic artifacts in the head (except dentures); Migraine; Brain tumor; Pregnancy; Breastfeeding patients; Uncontrolled intraocular pressure (IOP).